Xellera Therapeutics

Xellera Therapeutics, Ltd. is the center for cell and gene therapy development and manufacturing in Asia. Xellera Therapeutics operates Hong Kong's first commercial facility compliant with current Good Manufacturing Practice (cGMP) for clinical-grade cell and gene therapy products. The brand-new 22,000-square-foot, state-of-the-art cGMP production facility features Class B cleanrooms, quality control, process development, and research laboratories. It adheres to the standards of the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), PIC/S international guidelines, as well as Hong Kong’s local Ministry of Health regulations. It is specifically designed for the complex manufacturing processes of Advanced Therapy Medicinal Products (ATMPs) to ensure quality, safety, and efficacy.